Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Liposomal anthracyclines for breast cancer: overview.

× No keyword cloud information.

9 in total

1. Inducible release of particulates from liposomes using the mechanosensitive channel of large conductance and L-α-lysophosphatidylcholine.

Authors: Alexander Foo; Andrew R Battle; Gamma Chi; Ben Hankamer; Michael J Landsberg; Boris Martinac
Journal: Eur Biophys J Date: 2015-07-05 Impact factor: 1.733

2. Potentiation of the growth inhibition activity of 2-({4-[4-(acridin-9-ylamino)phenylthio]phenyl}(2-hydroxyethyl)amino)ethan-1-ol (CK0402) by Herceptin in SKBR-3 human breast cancer cells.

Authors: Yuan-Wan Sun; Ting-Kuang Niu; Jin-Ming Yang; Chul-Hoon Kwon; Kuen-Yuan Chen; Kun-Ming Chen
Journal: Exp Ther Med Date: 2010-05-01 Impact factor: 2.447

3. Enhanced delivery of chemotherapy to tumors using a multicomponent nanochain with radio-frequency-tunable drug release.

Authors: Pubudu M Peiris; Lisa Bauer; Randall Toy; Emily Tran; Jenna Pansky; Elizabeth Doolittle; Erik Schmidt; Elliott Hayden; Aaron Mayer; Ruth A Keri; Mark A Griswold; Efstathios Karathanasis
Journal: ACS Nano Date: 2012-04-13 Impact factor: 15.881

4. Microfluidic synthesis of PEG- and folate-conjugated liposomes for one-step formation of targeted stealth nanocarriers.

Authors: Renee R Hood; Chenren Shao; Donna M Omiatek; Wyatt N Vreeland; Don L DeVoe
Journal: Pharm Res Date: 2013-02-06 Impact factor: 4.200

Liposomal anthracyclines for breast cancer: overview.

1. Inducible release of particulates from liposomes using the mechanosensitive channel of large conductance and L-α-lysophosphatidylcholine.

2. Potentiation of the growth inhibition activity of 2-({4-[4-(acridin-9-ylamino)phenylthio]phenyl}(2-hydroxyethyl)amino)ethan-1-ol (CK0402) by Herceptin in SKBR-3 human breast cancer cells.

3. Enhanced delivery of chemotherapy to tumors using a multicomponent nanochain with radio-frequency-tunable drug release.

4. Microfluidic synthesis of PEG- and folate-conjugated liposomes for one-step formation of targeted stealth nanocarriers.

5. Yoctowells as a simple model system for the encapsulation and controlled release of bioactive molecules.

6. Comparison of safety and toxicity of liposomal doxorubicin vs. conventional anthracyclines: a meta-analysis.

7. Vitamin C-driven epirubicin loading into liposomes.

8. siRNA inhibition of telomerase enhances the anti-cancer effect of doxorubicin in breast cancer cells.

9. Enhancing the Effects of Low Dose Doxorubicin Treatment by the Radiation in T47D and SKBR3 Breast Cancer Cells.